Asakage Naoki, Kobayashi Shigeru, Gotou Tatsuya, Sasaki Morio, Tsukada Kenji, Suzuki Takahisa, Yamamoto Tetsurou, Sekine Masayuki, Miyazaki Eiji, Hirai Shu, Yamasaki Shigetaka
Dept. of Surgery, Tokyo Rinkai Hospital, 1-4-2 Rinkai-cho, Edogawa-ku, Tokyo 134-0086, Japan.
Gan To Kagaku Ryoho. 2007 Jun;34(6):919-23.
We report two cases of large gastrointestinal stromal tumor (GIST) of the stomach both of which were assessed as highly malignant, but took different clinical courses. Case 1: A 72-year-old male. Case 2: A 63-year-old female. The tumor size of Case 1 was suggestive of high malignancy, but only a partial gastrectomy was selected because it did not show any invasive findings. This patient has been followed up for 3 years post-operatively and no recurrence or metastasis has been noted. Case 2 had liver and lymph node metastases, which was consistent with high malignancy. We performed a total gastrectomy with distal pancreatosplenectomy and segmental liver resection. But after surgery, liver metastasis recurred therefore, imatinib mesylate was administered as adjuvant chemotherapy and since then, the tumor has been diminishing in size. No definitive evidence for adjuvant therapy has been established so far, but we suggest that post-operative adjuvant therapy is effective for high-risk GIST.
我们报告两例胃大胃肠道间质瘤(GIST),两例均被评估为高度恶性,但临床病程不同。病例1:一名72岁男性。病例2:一名63岁女性。病例1的肿瘤大小提示高度恶性,但由于未显示任何浸润性表现,仅选择了部分胃切除术。该患者术后已随访3年,未发现复发或转移。病例2有肝和淋巴结转移,这与高度恶性相符。我们进行了全胃切除术,同时行远端胰脾切除术和肝段切除术。但术后肝转移复发,因此给予甲磺酸伊马替尼作为辅助化疗,此后肿瘤体积一直在缩小。目前尚未确立辅助治疗的确切证据,但我们认为术后辅助治疗对高危GIST有效。